Product logins

Find logins to all Clarivate products below.


Electrophysiology Mapping and Ablation Devices | Market Insights | Europe | 2022

The Europe EP mapping and ablation device market will experience moderate growth through 2030 due to favorable reimbursement for ablation procedures, increasing ablation procedure volumes, and the uptake of premium-priced devices. Although the COVID-19 global pandemic had a significant impact on the European EP mapping and ablation device market, resulting in lost procedure volumes in 2020, market recovery is anticipated over the near term, and market growth will resume prepandemic trends within the first half of the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for EP mapping and ablation devices in Europe across an 11-year period.

Related Medtech Insights Reports

Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…